Motilal Oswal's research report on Godrej Consumer
GCPL’s 1QFY22 sales were in line with our estimates, while EBITDA margin was slightly better than expected, despite higher than anticipated gross margin pressures due to a lag between commodity cost increases and price hikes taken by the company. Continued double-digit two-year CAGR in the key domestic segments of Household Insecticides (HI) and Soaps, as well as improving performance in Africa were particularly encouraging highlights. We maintain our Buy rating as pieces of the growth puzzle that were missing earlier are gradually falling into place as highlighted in our detailed note on the company in Jun’21 as well as our upgrade note.
Outlook
Valuing GCPL at 45x Sep’23E EPS, we arrive at our TP of INR 1,140, a 17% upside to its CMP.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.